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Abstract
The mammalian cerebral cortex is critical for sensory and motor integrations and, 
for higher-order cognitive functions. The construction of mammalian cortical circuits 
involves the coordinated interplay between cellular processes such as proliferation, 
migration and differentiation of neural and glial cell subtypes followed by accurate 
connectivity evolving in complexity in primates. Alteration in cortical development 
may induce the emergence of various pathological traits and behaviours. Among the 
large array of factors that regulate the assembly of cortical circuits, serotonin (5-HT) 
plays important role as a developmental signal that impacts on a broad diversity of 
cellular processes. 5-HT plays distinct roles during specific sensitive periods and is 
produced from various sources depending on the perinatal stage. Its roles are medi-
ated by more than fourteen 5-HT receptors that are all G-protein coupled receptors 
except the ionotropic 5-HT type 3A receptor (5-HT
3A
) mediating rapid neuronal acti-
vation. Importantly, 5-HT metabolism and signalling are influenced by numerous epi-
genetic and genetic factors, including nutrition and gut microbiota, perinatal stress, 
infection and inflammation. In this review, we will recapitulate some evidences show-
ing that dysregulation of 5-HT homeostasis and 5-HT
3A
 signalling impairs distinct 
steps of cortical circuit formation leading to the predisposition of the onset of various 
psychiatric diseases.
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1. Introduction
The functions of the mammalian cerebral cortex are processed through the activation of multi-
partite neural networks composed of excitatory glutamatergic pyramidal neurons, local mod-
ulatory interneurons that release γ-aminobutyric acid (GABA), neuropeptides and vasoactive 
substances [1–5] and by ‘glial cells’ that do far more than just feeding neurones and scaveng-
ing debris [6, 7]. Developmental perturbations impacting the maturation of cortical circuits 
can trigger neuropsychiatric disorders [8–10]. Sensitive periods or windows of vulnerability 
have been demonstrated in various processes in particular for the rodent sensory systems as 
well as in the modulation of complex behaviours.
Mammalian cortical circuit formation is the result of a series of sequential events that take 
place mainly during embryonic and early post-natal development [11–14]. These events 
include the proliferation, migration and differentiation of neurons and ‘glial cells’ that are 
largely governed by genetic programs but are also sensitive to environmental factors. Such 
extrinsic signals are extremely diverse (including guidance cues, growth factors, cell adhesion 
molecules) and among them the monoamine serotonin (5-HT) has emerged as an important 
regulator of neural circuit formation [15, 16].
In mammals, cortical 5-HT arises from multiples sources depending on the developmental 
stage. At the onset of cortical development, 5-HT is of maternal and placental origin [17–19]. 
Later, by embryonic day 16 (E16 in mice) [15, 16, 20] and by gestational week 16 (GW16 in 
human) [13, 14], serotoninergic afferents invade the cerebral cortex and contribute to provide 
5-HT locally. Not surprisingly, like in non-mammalian species, serotonin modulates neuronal 
proliferation, migration and differentiation. In addition, 5-HT is implicated in the emergence of 
many neuropsychiatric disorders, including mental retardation, autism, depression and anxiety 
[10, 15, 21–26]. Importantly, 5-HT signalling is influenced by numerous epigenetic and genetic 
factors, including nutrition and gut microbiota [27, 28], perinatal stress [29–31], infection and 
inflammation [32–35], 5-HT metabolism and storage [15, 36–38], pharmacological compounds 
such as selective serotonin reuptake inhibitors [38–40] and genetic alterations [41–44].
Our aim is to give a comprehensive overview on the possible roles of 5-HT receptor signalling 
and 5-HT homeostasis on the development of the cerebral cortex in rodent and primate with 
a specific emphasis on human. In this framework, we will highlight more particularly recent 
studies that have revealed new molecular targets of early-life 5-HT in the construction of corti-
cal circuits; in particular, the ionotropic 5-HT type 3A receptor (5-HT
3A
). We will also review 
recent clinical studies suggesting that altered 5-HT homeostasis or signalling could participate 
in the emergence of human psychiatric disease, in particular of mood and anxiety disorders.
In the following section, we will describe the general structure of the mammalian cerebral cortex focus-
ing on rodent and then presenting the specificities observed in primate/human. Then we will describe 
the major steps of the development of the mammalian cerebral cortex that is governed by a series of 
sequential events including proliferation, migration and differentiation of neurons and glial cells. 
When numerous developmental similarities are observed very precociously in rodent versus primate, 
significant specificities arose later in development in primate especially in human.
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2. Structure and development of the mammalian cerebral cortex
2.1. Neuronal components and glial components
The mammalian cerebral cortex comprises of six lamina (layers), each containing specific com-
bination of neurons and ‘glial cells’. Cortical excitability is coordinated by the interplay of excit-
atory pyramidal neurons and inhibitory interneurons. Pyramidal cells, which make up the 
majority of all neurons in the adult cortex (80% in rodent cortex), are projection neurons that 
send axons to other areas inside or outside the cortex providing output excitatory drive by 
releasing glutamate [2]. Inhibitory neurons project locally, release the neurotransmitter GABA 
and refine cortical excitability. Although GABAergic interneurons are less abundant, they have 
crucial roles in the development and organization of cortical networks that underlie a wide 
range of cortical and mental functions [8, 45, 46]. They are extremely diverse, differing in shape, 
electrophysiological properties and in the combination of neuropeptides and calcium-binding 
proteins that they express in addition to GABA [1, 47]. To facilitate the description of GABAergic 
neurons, a consortium of experts has suggested using a unified nomenclature [4, 5]. Thus, one 
can distinguish four major and highly distinct classes of GABAergic neurons in the mamma-
lian cerebral cortex (Figure 1A). First, fast-spiking interneurons expressing parvalbumin (PV) 
that gate incoming sensory information [48, 49]. Second, adapting Martinotti cells expressing 
somatostatin (SOM) that control dendritic information through local feedback inhibition [50]. 
Third, adapting bipolar interneurons expressing mainly the vasoactive intestinal peptide (VIP) 
and calretinin (CR) that preferentially target other interneurons and receive direct input from 
the thalamus [20, 51, 52]. Fourth, adapting neurogliaform interneurons expressing vasoactive 
substances, notably the neuropeptide Y (NPY) and/or nitric oxide (NO) that are responsible for 
the slow GABAergic inhibition of pyramidal cells and interneurons and vasomotion [53–56].
Although these different types of interneurons have been identified in the primate or human 
cerebral cortex, their diversity largely surpasses what is observed in rodent [12]. Interestingly, 
unique to human cerebral cortex, bipolar/von Economo neurons are present in layer V of 
the anterior cingulate and fronto-insular cortices expressing VMAT2 [57, 58]. Their possible 
involvement suggested in neuropsychiatric disorders needs to be further investigated [59]. 
In human and primate, the neuronal composition of the cerebral cortex is less homogeneous 
between areas with a higher level of arealisation than in rodent. Interestingly, the density of 
small interneurons appears very high in associative areas [60].
Besides neurons, mature ‘glial cells’ have been shown to exert roles that are extremely more 
complex than previously thought. Astrocytes are the largest glial population in the mamma-
lian brain and are well-known to ‘feed neurons’ by transforming glucose into lactate that neu-
rons can directly use as ‘carburant’, to scavenge debris and to regulate neural transmission 
and ionic homeostasis of the brain [61, 62]. Microglial cells play a role of sentinels of inflam-
matory state of the brain. In addition to these roles, astrocytes and microglial cells participate 
in regulating cell proliferation, neuronal migration and plasticity (for review, see Refs. [6, 61, 
63]). Oligodendrocytes myelinate axons and increase their conduction velocity (they will not 
be further described in this chapter).
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Figure 1. Structure of the rodent cerebral cortex and relation with serotoninergic afferents. A, The four main classes of 
interneurons (NG: neurogliaform, PV: parvalbumin+, VIP: vasoactive intestine peptide+, SOM: somatostatin+) and their 
relationship with a typical pyramidal glutamatergic neuron (adapted from [64]). B, Serotoninergic afferents arising from 
the median raphe (MnR) are thin, diffuse and display small varicosities. Serotoninergic afferents arising from the dorsal 
raphe (DR) are thick, beaded, preferentially located in superficial layer and make true synaptic contacts with small 
interneurons expressing VIP and with NG interneurons expressing the 5-HT receptor type 3A (3A). Adapted from [65]. 
5-HT: serotonin.
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2.2. Development of the rodent cerebral cortex
The cerebral cortex develops from neuroepithelial germinal cells of the telencephalic pallium 
and subpallium that massively proliferate by E11-E12 in mice and GW5-6 in human, to form 
the cerebral vesicles [66]. At this stage, microglial cells—of extracerebral origin—have already 
started to invade the telencephalon (from E9.5 in rodent [67] and GW5 in human [63]) before 
blood vessels start to penetrate and ramify in the telencephalon [68]. They will both par-
ticipate in regulating neurogenesis [69]. The first generated neurons, Cajal-Retzius (C-R) cells 
and subplate cells (SP; from E10 in mice, GW5-7 in human), constitute transient and heteroge-
neous populations of cells that originate from both pallial and subpallial territories and form 
the preplate (PP; Boulder Committee; [66, 70, 71]). SP and reelin-secreting C-R cells provide 
positioning cues and instructions to developing cortical neurons and afferents [71–74]. The 
cortical plate, is formed from E13-E17 in mice and GW7-20 in human by post-mitotic excit-
atory pyramidal neurons migrated along radial glial (RG) fibres in an inside out gradient 
of development from layer VIa to layer II [13]. At the beginning of cortical plate formation 
(E13-E14 in mice), pyramidal cells are generated from radial glial cells (RGC), whereas later 
(E15-E17 in mice), they mainly originate from intermediate progenitor cells (IPC) or basal 
progenitors deriving from RGC cells [75, 76] (Figure 2).
The primate/human cortical neurogenesis is far more complex than that of rodent involving 
more germinal zones and a larger number of cell types [77, 78]. In particular, beside the early 
RGC in the VZ, a novel class of radial cells, the outer RG (oRG), located in the outer sub-
ventricular zone (SVZ) could be responsible for the increasing number of excitatory neurons 
and the formation of gyration in primate. The second stage of human cortical development 
(GW18-20) corresponds to the genesis of the supragranular layers that likely expand from the 
oRG [14] (Figure 2A).
In rodent, the cortical GABAergic interneurons are generated outside the cortical VZ, in the 
subpallium: mainly in the medial ganglionic eminence (MGE) (E11-E14 in mice) and the 
caudal ganglionic eminence (CGE) (E14-E17 in mice) [11, 20, 52]. These regions are specified 
through a combination of distinct transcription factors and morphogenes that produce dif-
ferent classes of interneurons [80]. The ventral and the dorsal parts of the MGE expressing 
the homeobox transcription factor Lhx6 generate fast-spiking/PV+ and adapting/SOM+ inter-
neurons [81–85]. The CGE, a region that expresses the transcription factor Gsh2, COUP-TFII 
but lacks the transcription factors Nkx2.1, Nkx6.2 and Lhx6 [80, 86, 87], generates VIP+, CR+, 
NPY+ and nNOS+ interneurons [20, 52, 85, 88]. Once produced, interneurons are targeted 
towards specific brain regions, including cortex, depending on the transcription factors and 
guidance cues they express [87, 89]. They initially follow parallel migratory streams, first 
in the IZ and MZ and later on along the SVZ, before they switch their migratory mode and 
incorporate into the developing CP through radial migration (see Figure 2B). In mice, corti-
cal migration is almost completed by P4, and is followed by cortical expansion. However, 
during the first two post-natal weeks and decreasing with age the SVZ retains the capacity 
to produce CR+ interneurons contributing to the pools of GABAergic neurons mainly popu-
lating lower cortical layers and cingulate cortex [90–92]. These events are recapitulated in 
Figure 3A and B.
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Figure 2. Early stages of development of the human (A) and mouse (B) cerebral cortex in relation with 5-HT afferents. 
A-B, Both in human and rodent intense proliferation of neuroepithelium and the formation of the preplate (PP) take 
place around (E10; GW5) and (E11-E12; GW6-7) respectively. By E13-E14 in mice and GW8-10 in human, PP is split 
by the migration of the first pyramidal neurons. Cajal-Retzius cells (C-R) will remain in the marginal zone (MZ) while 
subplate neurons (SP) will be positioned below the cortical plate (CP). In addition, in human around GW10, another 
source of progenitors arises: the outer radial glial (oRG) cells that do not maintain contacts with the apical surface. 
Monoaminergic axons and thalamocortical axons (TC) are already found in the MZ and in the intermediate zone (IZ) 
and, in the IZ respectively. By E15-E16 in mice most glutamatergic neurons are generated, 5-HT axons and TC run in 
the MZ and IZ and in the IZ respectively. By GW16 in human, SP occupy a large proportion of the cortical anlage and 
oRG are still producing a high amount of neurons. Interneurons migrating first tangentially to the pial surface and later 
radially to it, incorporating CP. C, Bars indicate the time at which different factors (maternal and environmental; 5-HT of 
placental origin, 5-HT produced by the embryo itself) could affect the development of the mouse embryo. A, is adapted 
from [20] and B is adapted from [13, 14, 79].
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In non-human and human primate, the origin of the very heterogenous GABAergic interneu-
rons is not so clear. Recently, studies have shown that in non-human primate, interneurons 
use a similar coding of transcription factors as in rodents and largely originate from the gan-
glionic eminences [93] (Figure 3C). However, a substantial proportion of them is likely to be 
generated in the pallium from the VZ and the SVZ [12, 94–96] (Figure 3C). Recently, migration 
of subclasses of human cortical interneurons has been reported to continue after birth [97].
2.3. Specificities of the human and primate cerebral cortex
As already mentioned, the first generated neurons, C-R and SP cells are located respectively 
in the presumptive Layer 1 and the SP zone of the human cortical anlage [66, 98, 99]. Specific 
to human, the SP zone is the largest transient compartment of the fetal neocortical anlage, 
about four times thicker than the cortical plate around midgestation [66, 100]. In humans 
and non-human primate, most SP neurons generated in the ventricular zone initially migrate 
radially, together with prospective layer VI neurons and secondarily get widespread into 
the expanding SP zone around midgestation [101]. Interestingly, at this stage, dispersion of 
SP cells in the extended SP zone is concomitant with the invasion of monoaminergic [102], 
thalamocortical and corticocortical axons in the cortical anlage [103]. SP zone begins slowly to 
disappear towards the end of gestation and during the early post-natal period. Finally, many 
Figure 3. Presumptive genesis of cortical GABAergic neurons in the rodent and human/primate embryos and fetuses. 
(A and B) In rodent, PV+ and SOM+ interneurons (INs) are generated first from the medial ganglionic eminence (MGE) 
located in the anterior telencephalon. CR+, VIP+ and neurogliaform INs are generated mainly in the caudal GE (CGE) 
and in the lateral GE (LGE) located in the basal ganglia and to a lesser extent in the anterior entopeduncular area 
(AEP) and in the pre-optic area (POA). (C) In non-human primate and in human, the picture is less clear. However 
transcription factors expression suggest that the GE produce a large part of GABAergic neurons. By contrast to rodent 
brain numerous, INs may be generated in the cortical anlage. Panel C is adapted from Ref. [12]. CR: calretinin, NG: 
neurogliaform, PV: parvalbumin, SOM: somatostatin and VIP: vasoactive intestine peptide.
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subplate neurons survive postnatally and transform into interstitial neurons of the subcortical 
white matter of the adolescent and adult brain [104]. GABA+ interstitial neurons express CB 
and CR [105]. Subcortical interstitial neurons in the white matter, which have been associated 
with a variety of neurological and psychiatric disorders of infant and adults, need to be fur-
ther investigated [105, 106]. Comparison of the rodent/human cortical development could be 
obtained by comparing Figure 2A with B and Figure 3A and B with C.
Microglial cells take part in normal establishment and maturation of neuronal circuitry 
during development [107]. In human, amoeboid microglial cells infiltrate the brain via the 
choroid plexus, the meninges and the ventricles around GW4,5, progressively colonize the 
cerebral wall from GW7 and became ramified [108, 109]. Passing through walls from GW10 
on. Interestingly, amoeboid microglial cells cluster in a band at the limit of the CP/IZ-SP zone 
at GW9-13 where early synaptogenesis takes place in the cerebral anlage [110]. They also clus-
tered in major axonal crossroads in the corpus callosum at GW16 and in the coronal radiata 
at GW19-24 [63]. Interestingly, this last fibres tract area is the target of white matter injury 
observed in inflammatory process of premature infant in cerebral palsy [111]. Similarly, a 
cluster of microglia/macrophages is detected in the cingulum bundle in the perinatal rat mod-
els of hypoxia and growth restriction developed by Verney and collaborators [112–114].
In mammals, the numerous cortical astrocytes are reported to be mainly generated not only 
from radial glial cells but also from other cell types that are not clearly elucidated such as 
progenitors in the SVZ [62]. Human astrocytes are far more complex in diversity and size, and 
the ratio of glia to neuron is higher when compared to rodent [115]. The protoplasmic and 
fibrous astrocytes appeared in waves in the cortical anlage [115], begin to differentiate around 
midgestation and co-expression between vimentin and GFAP is observed [116]. Functional 
Figure 4. Presumptive comparative schedule for development of the cerebral cortex in rat and human.
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astrocytes evolve in parallel with the maturation of the vascular endothelial cells involved 
in blood-brain barrier (BBB) formation [68, 117]. During development, monocarboxylates 
including lactate represent a major source of energy for the developing neurons [118]. The 
expression of monocarboxylate transporters such as MCT1 confirms the functionality of astro-
cytes in the energy trafficking occurring in the human visual cortex from GW19 [119].
Here, we provide a schematic drawing (Figure 4) comparing the schedule for the different key 
events occurring during the cortical development in human and in rat.
Serotonin is provided to the developing mammalian cerebral cortex via many sources. Numerous stud-
ies, cited in the section below, have described this in rodent but only sparse data are available in primate 
especially in human.
3. Sources of serotonin to the mammalian cortex
3.1. Serotonin synthesis and degradation
Serotonin is synthesized from the essential amino acid tryptophan. In the blood stream, tryp-
tophan is linked to serum albumin but a proportion that decreases with age is free to cross 
the BBB (10% at post-natal day 12 when BBB is thought fully functional [120]). Tryptophan 
is then transported, accumulated in 5-HT-producing cells and hydroxylated by the trypto-
phan hydroxylase enzymes (Tph). Tryptophan hydroxylase type 2 (Tph2) is expressed in 
serotoninergic neurons of the raphe nuclei and myenteric neurons [121, 122], while Tph1 is 
expressed in the pineal gland, in the placenta and in various peripheral tissues [18, 19, 122, 
123]. 5-hydroxytryptophan is then further decarboxylated into 5-HT by the aromatic amino 
acid decarboxylase (AADC). The availability of tryptophan to synthesise 5-HT depends on 
the inflammatory status of the organism. In case of inflammation, indoleamine 2,3-dioxygen-
ase (IDO) is generated, which can lead to 5-HT depletion in the organism [35].
5-HT is catabolized by monoamine oxidases A or B (MAOA or MAOB [124, 125]). MAOA 
has higher affinity for 5-HT than MAOB and is strongly co-expressed with MAOB between 
E12 to P7 in rodent serotoninergic neurons [126]. After P7, the expression of MAOB is 
largely predominant in 5-HT+ neurons [126]. MAOs are also expressed by many non-amin-
ergic structures, in particular the placenta and in a subpopulation of VZ-SVZ cells ([126, 
127] and our unpublished results) where they may regulate the amount of 5-HT locally. 
Interestingly, MAOs expression and protein synthesis are tightly regulated and have been 
shown to be sensitive to environmental factors such as inflammation and ischaemia-like 
conditions [34].
During embryonic development, the telencephalon receives 5-HT arising from multiple 
sources that are mainly of extra-embryonic or maternal origin at the beginning of gestation. 
Later, they progressively arise from different embryonic regions. Below, we will briefly reca-
pitulate the sources of serotonin provided to the embryonic telencephalon in relation with 
cortical development.
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3.2. Development of the serotoninergic neurons and projections
In mammals, brainstem serotoninergic neurons are subdivided into 9 groups (B1–B9) forming 
a caudal and a rostral division. The rostral division (B5–B9; including the dorsal (B6, B7) and 
median raphe nuclei (B5, B8)) projects to the forebrain [65, 128, 129] (Figure 1B). Since these 
initial descriptions, recent mapping of 5-HT projections have been performed in mice reveal-
ing a higher level of refinement in the projections of raphe clusters towards specific targets 
[130]. Such level of analysis is lacking in primate and human.
In mice, the rostral division differentiates by E10-E11 (E12-E15 in rats); dorsal and median 
raphe send axons that reach the cortico-striatal junction by E14 in mice before entering the 
cortical anlage as two tangential streams, one above and the other below the CP [131, 132]. In 
the MZ, C-R cells and serotoninergic axons are in close apposition and make transient synap-
tic contacts [133, 134]. Below the CP, 5-HT afferents are mainly restricted to the IZ and the SP 
[131]. By E16-E17 in mice, thalamocortical axons (TCAs) invade the cortical anlage and are in 
close apposition with 5-HT axons running in the IZ. At the end of corticogenesis, 5-HT axons 
gradually arborize, sending numerous branches into the CP [131].
By P21, serotoninergic axons become evenly distributed in the different cortical territories 
showing their mature pattern of innervation [128]. Dorsal raphe axons are generally thin with 
pleiotropic varicosities that preferentially arborize in cortical layers IV and V. By contrast, 
median raphe axons show large spherical varicosities, form true chemical synapses, preferen-
tially arborize in layer I and lower white matter, and contact interneurons containing VIP and 
cholecystokinin (CCK) [64, 65, 135] (Figure 1). Thus, 5-HT could be released along the entire 
axonal network through volume transmission or in synaptic clefts.
Anatomical studies have described the primate raphe nuclei and the serotonergic cor-
tical innervation at mature stages [136–138], but only a few studies have reported their 
development. In Rhesus monkey, the genesis of raphe neurons was detected in the first 
quarter of gestation (E28-E45, birth: E165) [139] and 5HT+ fibres were reported in the ento-
rhinal cortex at E70, similarly to tyrosine-hydroxylase+ catecholaminergic axons [140]. In 
human cortical anlage, one can suggest that the early afferents of serotoninergic axons as 
described for the catecholaminergic afferents may penetrate the cortical anlage around 
GW8 and invade the fetal cortex at midgestation in a mature-like pattern [102, 141]. In par-
allel, SERT expression in developing TCAs have been detected at GW10 in human cortical 
anlage [142]. Comparable expression has been described for the visual sensory system in 
the marmoset [143].
3.3. Other sources of serotonin
The first demonstrations showing that 5-HT was influencing very early embryonic devel-
opment were provided by pioneer groups showing that ex vivo application of 5-HT or alter-
ation of 5-HT levels altered normal development of various embryonic structures before 
serotoninergic neurons have innervated these structures [144–149]. Several studies suggest 
that 5-HT derives from maternal or placental sources (see Figure 5 that recapitulates those 
studies).
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Figure 5. Maternal, placental, genetic and pharmacological conditions determining the amount of serotonin supply 
to the developing telencephalon. Tryptophan is provided to the embryo but could also be converted into 5-HTP 
(5-hydroxytryptamine) or further into serotonin (5-HT) in the placenta via the expression of various metabolic enzymes 
expressed in the placenta. In addition, 5-HT from maternal sources could be taken up by the placenta that also expressed 
serotonin transporter (SERT). During early embryonic stages 5-HT could be delivered directly to the developing 
embryo. After E15-E16, when 5-HT axons of the hindbrain reach the cortex, 5-HT could act on various target cells (Cell) 
expressing selected arrays of 5-HT receptors. At this stage 5-HT could also be taken up and stored by thalamocortical 
afferents (TC) and released after specific stimulation. In addition 5-HTP is provided to the (tryptophan hydroxylase type 
2) Tph2 and the (aromatic amino acid decarboxylase) AADC containing neurons that synthetize 5-HT. In this drawing 
adapted from [19], we have pointed in the large left arrow the maternal conditions that are best known to interfere with 
5-HT availability to the embryo. We have also indicated that inhibitors of 5-HT uptake (SSRIs) that cross all barriers 
affect SERT function at all levels. Genetic polymorphisms or methylations mentioned in the text are indicated by a star. 
The major catabolic enzymes of 5-HT, monoamine oxidases are indicated (MAO). Tryptophan hydroxylase type 1; Tph1.
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Several groups have suggested that, at early stages, 5-HT arises from maternal sources. Indeed, 
this was suggested when analysing the phenotype of embryos generated from Tph1+/− or Tph1+/+ 
mothers. Tph1−/− and Tph1+/− embryos obtained from crosses between heterozygous parents were 
indistinguishable from their wild-type littermates (the crown-rump length (CRL) was of 7.4–
7.5 mm). By contrast, 80–88.9% of Tph1−/− and Tph1+/− embryos born Tph1−/− mothers displayed 
low CRL values (5.8–7.4 mm). This suggests that the partial lack of maternal 5-HT provided 
to the embryo may be sufficient to explain some of the littermates phenotypes [18, 123].
Recently, the placenta (that is of embryonic origin) has been identified as an important source 
of 5-HT for the developing embryo. The placenta (syncytiothrophoblastic cells and sinusoi-
dal throphoblastic giant cells) of the placenta contain Tph1, AADC and MAO [124, 125, 127], 
and convert tryptophan of maternal origin into 5-HT as soon as E10-E11 [150]. Homozygote 
knock-out embryos in which 5-HT neurons fail to fully differentiate or to produce normal 
amounts of 5-HT levels do not display severe cortical defects when gestating in heterozygous 
dams. Examples include mice lacking the transcription factors Lmx1b [151] or Pet-1 [152], in 
which all or 70–80% of 5-HT raphe neurons fail to develop, and mice lacking Tph2 [153, 154]. 
Further analysis revealed that Pet-1 knock-out embryos developing in heterozygous dams 
have normal 5-HT levels before the closure of the BBB (before E15 [68]). These studies suggest 
that 5-HT produced by the placenta may buffer maternal deficiency. However, the compensa-
tory mechanisms remain to be clarified.
Outside the CNS, 5-HT is also produced in the periphery of the developing embryo: from 
the myenteric plexus (from E15-E16), from enterochromaffin cells of the lining lumen of 
the digestive tract (from E18), from neuroepithelial cells of the respiratory tracts, from the 
parafollicular cells of the thyroid and from pinealocytes (belonging to the CNS; from E12). 
5-HT could also be taken up by SERT expressing cells and further delivered to a distant 
region. SERT is expressed in platelets and mast cells [155, 156] that become numerous 
around E12 in mice. These cells could cross the BBB, transit across blood vessels that start 
to invade the developing cortex by E10-E11 in mice [68]. Whether these structures and 
mechanisms provide substantial amount of 5-HT to the developing telencephalon remains 
to be clarified.
Transiently, sensory thalamic neurons express SERT (E15-P15 in mice) and the vesicular mono-
amine transporter type 2 (VMAT2) that are respectively responsible for the uptake and packag-
ing of 5-HT into synaptic vesicles [37, 157, 158]. Sensory thalamic neurons do not contain MAOs 
[159] but are equipped to release 5-HT, possibly with other transmitters (e.g. glutamate), after 
specific stimulation (review in Ref. [15]). Interestingly, it has been suggested that thalamocorti-
cal axons (TCAs) could be implicated in the proliferation and migration of glutamatergic neu-
rons [160, 161] in addition to their well-known role on axonal refinement (see below).
Tryptophan is provided to the embryo but could also be converted into 5-hydroxytryptamine 
(5-HTP) or further into serotonin (5-HT; violet) in the placenta via the expression of various 
metabolic enzymes expressed in the placenta. In addition, 5-HT from maternal sources could 
be taken up by the placenta that also expressed serotonin transporter (SERT). During early 
embryonic stages, 5-HT could be delivered directly to the developing embryo. After E15-E16, 
when 5-HT axons of the hindbrain reach the cortex, 5-HT could act on various target cells 
(Cell; maroon) expressing selected arrays of 5-HT receptors. At this stage, 5-HT could also be 
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taken up and stored by thalamocortical afferents (TC) and released after specific stimulation. 
In addition, 5-HTP is provided to the tryptophan hydroxylase type 2 (Tph2) and the aromatic 
L-amino acid decarboxylase (AADC) containing neurons that synthesize 5-HT. In this drawing 
adapted from Ref. [19], we have pointed in orange the maternal conditions that are best known 
to interfere with 5-HT availability to the embryo. We have also indicated that inhibitors of 5-HT 
uptake (SSRIs) that cross all barriers affect SERT function at all levels. Genetic polymorphisms 
or methylations mentioned in the text are indicated by a star. The major catabolic enzymes of 
5-HT, monoamine oxidases (MAO) are indicated.
Serotonin receptor signalling has been shown to regulate various cellular events. However, the large 
spectrum of serotonin receptors still need to be investigated in cortical development in rodent and even 
more in primate.
4. Serotonin receptors with specific attention to the 5-HT
3A
4.1. Transducing pathways
At least fourteen genes encoding for 5-HT receptors have been identified and cloned in the 
mammalian brain [162–165]. In addition, isoform diversity, alternative splicing of some sub-
types and RNA editing add to the diversity of serotoninergic receptors. With the exception of 
the 5-HT
3
 receptors, all 5-HT receptors are coupled to G-proteins. According to their second 
messenger coupling pathways, 5-HT receptors have been categorized into four groups. The 
5-HT
1 
and 5-HT
5
 receptors are coupled to Gi/Go proteins and exert their inhibitory effects on 
adenylate cyclase, inhibiting cAMP formation. The 5-HT
2
 receptors are coupled to Gq pro-
teins and stimulate phospholipase C to increase the hydrolysis of inositol phosphates and 
elevate intracellular Ca2+. The 5-HT
4,6,7
 receptors are coupled to Gs proteins and are positively 
linked to adenylate cyclase and increase cAMP formation. 5-HT
3
 receptors belong to a family 
of ligand-gated ion channel receptors that include nicotinic acetylcholine receptors, GABA
A
 
receptors and glycine receptors and are modulated by intracellular cyclic AMP [162]. The 
5-HT
3 
receptors respond to neurotransmitter release via direct (through the 5-HT
3
 receptor 
itself) or indirect activation of the voltage-gated Ca2+ channels and lead to Ca2+ entry into the 
cell [166]. 5-HT
3
 receptors are composed of five subunits, with the majority being homomers 
of 5-HT
3A
 receptors. Heteromeric 5-HT3AB receptors have been observed in specific brain 
regions and display lower Ca2+ permeability than the homomeric 5-HT
3A
 receptors [167–169].
4.2. Expression patterns
Despite the efforts of many laboratories and open databases, a complete description of the devel-
opmental expression pattern of 5-HT receptors in the cerebral cortex is still lacking in rodent and 
very few studies have been performed in primate. However, pictures are emerging in the rodent 
brain. For example, 5-HT
1A,F
 are expressed in neocortical proliferative zones in E14.5 rodent brain 
[17] and the 5-HT2B are expressed in the proliferative zones of the human occipital cortex [129] 
and in all microglial cells [170, 171]. The 5-HT1A,B,D, 5-HT2A, 5-HT2C and 5-HT3A, are expressed in specific subpopulations of post-mitotic neurons [17, 88, 91, 167, 168, 172, 173], whereas the 5-HT
6
 
is expressed in both migrating interneurons and pyramidal neurons [174, 175].
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The dynamic expression pattern of the 5-HT
3A
 receptor has been described in details recently 
in mice. In the developing cortex, 5-HT
3A
 is expressed as early as E11-E12 in neurons express-
ing reelin (Cajal-Retzius cells) and/or GABA cells located in the PP [88, 173]. The 5-HT
3A
 is 
expressed by newly post-mitotic GABAergic neurons located in the CGE and AEP/PO, where 
about 30% of cortical GABAergic neurons are generated ([52, 88]; see Figure 3A and B). Using 
homochronic in utero grafting in combination with a transgenic mouse line expressing GFP 
under the control of the 5-HT
3A
 promoter (5-HT
3A
:GFP animals), we have shown that this expres-
sion was protracted in two large subpopulations of cortical GABAergic neurons: the multipo-
lar interneurons expressing NPY displaying late spiking and accommodating properties and 
in VIP+ interneurons displaying adapting and bursting properties [52, 88, 176]. In addition, 
subpopulations of NO+ and reelin+ interneurons also express 5-HT
3A
 ([52, 55]; Figure 1A). 
By post-natal stages and decreasing with age, 5-HT
3A
 is also expressed by young neurons 
expressing doublecortin and/or calretinin generated in the SVZ and migrating towards the 
olfactory bulb (rostral medial stream) and various cortical and subcortical regions [90, 91]. In 
addition, we have reported that transient-amplifying precursors located in the white matter 
ventrally to the anterior cingulate cortex produced neurons destined to populate the anterior 
cingulate cortex and its vicinity [91].
Serotonin homeostasis and signalling act as a sculptor of cortical circuitry. In this section, we will 
review the different steps of cortical assembly that have been shown to be modulated by serotonin.
5. Impact of serotonin imbalance on cortical circuit assembly
5.1. Serotonin and cell proliferation
It has been postulated for some time that 5-HT regulates the proliferation of a wide variety of 
cell types including cortical neurons. Pharmacological studies inducing depletion of several 
monoamines triggered drawbacks due to the non-selectivity of the drugs used and they will 
not be discussed here.
Recently, transgenic models selectively targeting specific serotonin-related genes in differ-
ent neuronal populations have started to provide more insights. For instance, mice defi-
cient in Tph1 or Tph2 showed body weight reduction and delayed maturation of cortical 
layers [18, 153, 177]. Heterozygous embryos growing in null mutant Tph1−/− mice showed 
an average of 30% reduction in proliferating cells (BrdU+) in the VZ after a 2 h pulse of 
BrdU administration, an analog of thymidine that is incorporated during the S phase of 
the cell cycle [18]. Although these studies suggest that 5-HT from Tph1+ sources may regu-
late the proliferation of neuronal precursors, additional studies are needed to refine these 
observations.
Hyposerotonin-induced microcephaly could also be due to increased death of post-mitotic 
neurons or neuronal progenitors. Indeed, 5-HT
2
 stimulation promotes the survival of gluta-
matergic neurons in vitro with a maximal effect observed for stages E16 and E18 in rats [178], 
and 5-HT
1A 
stimulation increases neuroprotection in models of ischaemia and protects neu-
ronal cultures against serum withdrawal [179, 180]. Furthermore, activation of 5-HT
2
 reverts 
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increased apoptosis observed in VMAT2:KO mice, in which dopamine, norepinephrine and 
5-HT are depleted [181].
The analysis of mice lacking MAOA and B, which displays high 5-HT levels but normal 
dopamine and norepinephrine levels during development, revealed a specific reduction of 
symmetric divisions of intermediate precursors cells [76] in SVZ during late corticogenesis 
(E17.5) [182]. This unexpected alteration was reverted after pharmacological inhibition of 
5-HT synthesis (with p-chlorophenylalanine; PCPA) between E14.5-E19.5. In addition, neuro-
sphere formation was modulated by 5-HT in a dose-dependent manner in vitro, with prolif-
erative effects observed for concentration ranging from 10 to 100 ng/ml and inhibitory effects 
observed for higher concentration (1000 ng/ml). In this study, these inhibitory effects were 
associated with decreased 5-HT
1A
 labelling of neuronal precursors [182] previously known 
to trigger neurogenesis in adult dentate gyrus. Hence, 5-HT might modulate cortical density 
through its proliferation-inducing action on progenitors.
During early development, 5-HT could also promote gap junction coupling through 5-HT
2
 
stimulation [183] that coordinates cell-cell assembly during cell cycle [184].
5.2. Serotonin and neuronal migration
In most phyla, 5-HT triggers motility of various cell types including vertebrate lymphocytes 
(chick, fish, rodent [185, 186]) and microglia towards the CNS [170]. In the mammalian cortex, 
a role for 5-HT in regulating the migration of cortical neurons has recently emerged. In this 
context, 5-HT produces opposite consequences depending on its concentration.
One of the first experiments to address this question was made ex vivo on cortical explants main-
tained in a serum-free medium and supplemented with low 5-HT concentration. The migra-
tion of glutamatergic neurons was examined and was found be faster in explants supplied 
with 5-HT suggesting that low 5-HT dosage may enhance the radial migration. Furthermore, 
decreasing 5-HT levels during development delayed or disrupted cortical migration, sug-
gesting that 5-HT produces a positive drive on cortical migration [181]. In rats depleted in 
5-HT by PCPA during the peak of migration (E12/E13 to E17 in rats), abnormal accumulation 
of GABAergic neurons below the subplate at E17 and a marked reduction of calretinin+ and 
CCK/VIP+ GABAergic neurons at adult stage were reported [187]. Interestingly, mice lacking 
Tph2 also display reductions of selective GABAergic populations in limbic structures [188]. 
5-HT
3A
 is protractedly expressed by 30% of GABAergic neurons leading to calcium entry into 
the cell (see above). Using electrophysiological recording and calcium imaging, it was recently 
shown that CGE-derived interneurons that expressed 5-HT
3A 
increase their response to 5-HT
3
 
activation while they migrate radially and integrate the cortical plate (late phase of migration; 
see Figure 6A). This activation leads to an increased growth cone activity and to a decrease 
resting-state of 5-HT
3A
+ interneurons. Further, using in vivo graft of 5-HT
3A
 deficient inter-
neurons into wild-type host, it was shown that this role was cell-autonomous. Interestingly, 
long-lasting alteration in the positioning of reelin+ cortical interneurons was reported. This 
suggests that 5-HT
3A
 activation acts as a migratory signal for CGE-derived interneurons and 
alters definitively the positioning of their subpopulation [189]. A similar conclusion was sug-
gested using SERT:KO animals that showed a specific increase in the migratory speed and 
positioning of VIP+ interneurons [92].
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Although dynamic expression pattern of 5-HT receptors is lacking in developing primate and 
human cortex, a very recent study by the group of Alvarez-Bulla showed that in human, late-
born interneurons continue to migrate in the cingulate cortex even after birth. These interneurons 
expressed a combination of transcription factors and a substantial fraction of them expressed 
COUP-TFII or SP8 (22 or 28% respectively) that are mainly specific of 5-HT
3A
+ interneurons sug-
gesting that 5-HT could also modulate the migration and positioning of these neurons in human 
[97]. Interestingly, in the primate cortex, it was shown that 5-HT
3A
 is expressed by a subset of 
small GABA+, substance P+ or calbindin+ neurons and by medium-size CR+ neurons [190].
By contrast, 5-HT excess appears to have opposite role on migrating neurons. Using high dos-
age of 5-HT ex vivo on cortical slices, it has been shown that 5-HT induces a decrease in the 
Figure 6. Modulation of cerebral circuit formation by 5-HT
3A
 A, 5-HT
3A
 (3A) is expressed by migrating interneurons 
generated in the caudal ganglionic eminence (CGE). Physiological concentration of serotonin (5-HT), induce an 
acceleration of the radial migration of 5-HT3A+ interneurons at E17. B, At early postnatal stage, Cajal-Retzius cells (C-R) 
that express 5-HT
3A
, respond to 5-HT application by releasing reelin that through the activation of the integrin signaling 
pathway induce pruning of apical dendrites of pyramidal neurons (Pyr). This figure is adapted from [200].
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migratory speed of non-GABAergic and GABAergic neurons [174]. High 5-HT levels induced 
a retraction of the leading processes of GABAergic neurons migrating into the intermediate 
zone and cortical plate. This effect was shown to be mediated, at least in part, by the 5-HT
6
 
receptor activating the cAMP-signalling pathway [191]. Such role was also reported for gluta-
matergic neurons (for review, see Ref. [175]).
5.3. Serotonin and differentiation of cortical neurons and afferents
Lauder and Krebs were the first to report that depletion of 5-HT delayed the cessation of cell 
division, a marker of cell differentiation [144, 192]. After these pioneering studies, numerous 
groups have shown that 5-HT can influence dendritic and axonal morphogenesis during cor-
tical development.
5.3.1. Serotonin and dendritic maturation of cortical neurons
5-HT was shown to regulate the physiology of C-R cells known to be key regulators of various 
aspects of cortical development including dendritic arborization. This role is largely mediated 
by the secretion of the glycoprotein, reelin [72, 74]. C-R cells receive serotoninergic projections 
with which they make transient synaptic contacts [134] and reelin secretion was shown to be 
regulated in part by the amount of brain 5-HT. Pharmacological perturbation of the serotonin-
ergic system by 5-methoxytryptamine (a non-selective 5-HT receptor agonist) reduces reelin 
levels circulating in the blood flow at P0 [134], leading to the formation of abnormal micro-
columns in the mice P7 presubicular cortex, a feature that is observed in autistic syndromes 
(ASDs). The activation of C-R cells was proposed to be modulated by 5-HT
1A
 or by the 5-HT
3A
 
receptors, as they were both suspected to be expressed in the marginal zone during develop-
ment [167, 193]. Interestingly, the 5-HT
3A
 has been shown to be expressed by C-R cells (aver-
aging 80% at P0) and the synaptic activation of 5-HT
3A
 was shown to be sufficient to induce 
action-potential firing on C-R cells suggesting that 5-HT
3A
 could play a role in dendritic devel-
opment [173]. The contribution of the 5-HT
3A
 was further analysed. The deletion or blockade of 
5-HT
3A
 receptors was shown to induce excessive arborization of layers II-III apical dendrites of 
pyramidal neurons. Application of the N-terminal region of reelin, that induces the activation 
of a signalling pathway that is independent from the classic ApoER2/VLDL-pathway, rescued 
the dendritic phenotype of cortical pyramidal neurons in 5-HT
3A
:KO cortical slices, whereas 
reelin blockade leads to an increased growth of apical dendrites ([173]; see Figure 6B). This 
study suggested that increased reelin secretion due to over-activation of the 5-HT
3A
 receptor 
could induce a decreased growth of apical dendrites. Interestingly, fluoxetine (an inhibitor of 
5-HT uptake, SSRI) administration from E8 to E18 decreased the dendritic basal and apical 
arbor complexity of layer II/III pyramidal neurons in the somatosensory cortex. Such a role is 
specific to a selective developmental period and SSRIs have opposite functions at mature stages 
[194]. Furthermore, the effects of SSRIs on developing dendrites were abolished when adminis-
tered in the 5-HT
3A
:KO mice or after pharmacological blockade of the 5-HT
3A
 receptor [173, 195]. 
Moreover, the fine tuning of 5-HT
3A 
signalling has been shown to be responsible for the anxi-
ety-like behaviours that are induced by prenatal fluoxetine treatment in wild type mice [196]. 
These results suggest that developmental excess of serotonin increases reelin secretion by over-
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activating 5-HT
3A
 receptors expressed on C-R cells, consequently inhibiting dendritic growth of 
pyramidal neurons. Whether 5-HT
3A
+ interneurons participate in this process remains unclear.
Animals fed with low tryptophan diet [197, 198] display cortical pyramidal neurons with 
decreased dendritic complexity and spine density. Thus, 5-HT may regulate dendritic matu-
ration and spine density through different types of 5-HT receptors that remain to be identi-
fied. In this respect, the 5-HT
1A
 is strongly expressed in the developing cortical plate [17] and 
is known to be necessary for the dendritic maturation of CA1 pyramidal neurons [199]. The 
5-HT
6
 receptor also appears as a good candidate for controlling neuritic and dendritic devel-
opment due to its ability to engage signalling pathways (e.g. Fyn, mTOR and Cdk5) playing 
roles in these processes. In vitro studies strongly suggest a role of 5-HT
6
 on neuritic extension 
(for review see [175]). However, a clear view on the implication of the variety of 5-HT recep-
tors expressed in the developing cortex remains to be elucidated.
5.3.2. Serotonin and axonal development within the cerebral cortex
The first clear demonstration that serotonin acts on cellular processes involved in the forma-
tion of cortical circuits comes from works performed on the rodent barrel field in the somato-
sensory cortex (S1). The serendipitous generation of a mouse displaying deficiency in the 
gene encoding for MAOA was at the starting point of these discoveries. These studies showed 
that excessive 5-HT amounts (ninefold increase at P0) in the developing cortex induced an 
abnormal organization of thalamocortical afferents (TCAs) growing in the layer IV of the pri-
mary somatosensory cortex [36, 37]. These alterations were later interpreted as an abnormal 
refining of TC axons due to a specific rise of 5-HT occurring during a sensitive period (P0-
P4: [201]). In addition, pharmacological normalization of 5-HT levels in MAOA:KO mice by 
P0-P4 PCPA-treatment was sufficient to revert to normal the organization of S1 in MAOA:KO 
mice [37]. Later, it was shown that genetic SERT deficiency affected S1 organization similarly 
in rodent. These alterations are not only structural but also impair whisker-mediated per-
ception [10]. Hyper-activation of the 5-HT1B receptor, transiently expressed on TCAs during 
development, plays a key role in this process. Indeed, SERT:KO and MAOA:KO mice that 
are deficient in 5-HT1B receptors are rescued [202–205]. Interestingly, serotonin excess does 
not only impairs S1 organization, but also such a role could probably be generalized in other 
regions displaying transient 5-HT uptake [158] as this was shown for the visual system [202, 
205, 206]. Moreover, such a role could also occur in primate cortex since SERT is transiently 
expressed in the visual sensory thalamic neurons, at least in the marmoset [143]. So far due 
to the difficulty to obtain human embryonic samples of late stages, clear sets of data are still 
lacking but numerous non-serotoninergic fibres, presumably TCAs, labelled by SERT have 
been detected at GW10 [142].
Surprisingly, perinatal 5-HT deficiency only induces a reduction of barrel field organization 
without altering its general organization [177, 207, 208]. Nevertheless, further studies need to 
be carried since early reduction of 5-HT during embryonic development induces the emer-
gence of altered behaviour [153].
Other studies suggest a prenatal role for 5-HT in regulating initial TCAs pathfinding. TCAs 
express SERT, 5-HT1B and 5-HT1D receptors at a time when TCAs are navigating towards the 
pallium. Embryonic down-regulation of 5-HT1B/C receptors in TCAs using in utero electropora-
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tion leads to abnormal TCAs pathfinding [209]. Furthermore, it has been shown that 5-HT 
modifies the attractive versus repulsive responsiveness of TCAs to netrin-1 [209], an impor-
tant guidance molecule for TCAs. Given these findings, it is thus likely that abnormal 5-HT 
levels could also affect these earlier stages of TCAs pathfinding and lead to abnormal long 
range of TCAs wiring [19, 150].
5.4. Serotonin and the regulation of astrocytes and microglial cell functions
Astrocytes and microglial cells have been shown to be implicated in key processes—from 
neurogenesis to synaptogenesis—involved in cortical development (for review, see Ref. [61]). 
These cells bear several 5-HT receptors depending on their stage and state (resting or acti-
vated) making 5-HT an indirect actor of cortical development via the modulation of their 
functions [170]. Pioneer studies have shown that 5-HT
1A
 and 5-HT
2
 are expressed by both 
immature and mature astrocytes in human and rodent cortex, and that 5-HT stimulates the 
release of several trophic factor produced by glial cells that promote neuritic extension and 
synaptogenesis of cortical and serotoninergic neurons such as S100β or BDNF. Conversely, 
lesions of the serotoninergic system were shown to increase GFAP and to decrease the release 
of several trophic factors [210, 211].
More recently, several groups have focused their attention on the implications of microg-
lial cells that colonize the embryonic telencephalon at the very beginning of its formation in 
rodent and human (see above; [63, 212]). Through local phagocytic activities and the release 
of various molecules (such as interleukin-1beta or tumor necrosis factor-alpha), microglial 
cells have been shown to regulate neurogenesis, to participate in axonal and dendritic orga-
nizations and pruning [212–216]. From early stage of colonization, microglial cells have been 
shown to express, at least, the 5-HT2B receptor and at later stages or upon stimulation (such as inflammation), several other 5-HT receptors have been detected in rodent (5-HT1F,2A,2B,3B,5A 
and 5-HT
7; 
[170]). The activation of these receptors has been shown to regulate their motility, 
their phagocytic properties and selective reshaping of axonal and dendritic arborizations. For 
instance, 5-HT2B has recently been shown to induce synaptic refinement of retinal projections 
to the thalamus since this process is impaired in mice lacking 5-HT2B selectively in microglial 
cells [171].
During early development, the serotoninergic system is challenged by various genetic and epigen-
etic factors such as medications altering 5-HT transporter function, by nutrition and stress including 
ischaemia/hypoxia. In this section, we review how these factors may induce the emergence of various 
pathological disorders in primate and human.
6. Serotonin imbalance and consequences in human pathology
6.1. Serotonin imbalance and 5-HT
3 
receptor modulation in human pathology
Developmental imbalance of 5-HT homeostasis or serotonin receptor signalling impacts vari-
ous processes involved in the formation of cortical circuits and has consequences on the emer-
gence of abnormal behaviour in rodent. Some similarities have been detected in primate and 
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human but many aspects remain to be tested, in particular, the cellular processes implicated 
(conditioned by SERT or 5-HT receptors expressions) and the time windows of vulnerability.
In human, three major causes of 5-HT imbalance leading to psychiatric diseases have been 
clearly identified: abnormal metabolism of 5-HT, exposure of fetuses to SSRIs and genetic 
inheritance of SERT variants (these points of vulnerability have been indicated in Figure 5). 
Following the discovery of the lack of MAOA in Norrie disease [217], abnormal regulation of the 
enzymes implicated in 5-HT metabolism has been known for long to be associated with neuro-
psychiatric diseases (recently reviewed by Naoi et al. [218]). However, it is not known whether 
the alteration in prenatal or post-natal human life induces such illness. Pharmacological SSRIs 
treatment gave clearer answers. Indeed, SSRIs during pregnancy are still largely used among 
women ((2–13%) [219]); despite the high incidence of mood disorders in pregnant women 
(around 20% of pregnant women are affected) and the deleterious effect of maternal stress on 
fetal development. However, SSRIs crossing the placenta, are detectable in breast milk, reach 
the developing brain. Both, short-term (e.g. fetal cardiovascular malformations) and long-term 
drawbacks of the treatments have been revealed (see below). During gestation, SSRIs induced 
a reduction of blood flow in the middle cerebral artery at GW36 [220] and reduced fetal head 
growth [221]. SSRIs induce reduced motor movements and altered speech perception at 6–10 
months of age, increased irritability, and persistent blunted pain reactivity [222, 223]. Children 
exposed to SSRIs during pregnancy have poor scores on psychomotor developmental scales 
[224] and higher risks to develop autism spectrum disorders [225]. The risk appeared higher 
when exposure to SSRIs occurred during the second trimester and with higher dosage of SSRIs, 
suggesting deleterious effects on early neural circuit formation. The third well-known cause of 
excessive 5-HT-signalling in human is of genetic origin. There are two variants of SERT alleles 
leading to different levels of SERT expression: the short form that induces decreased levels of 
SERT expression and SERT hypofunction [41] and the long form. Hypofunctional s-allele has 
been shown to increase the risk for a wide range of psychopathological traits. When combined 
with maternal anxiety during pregnancy, infants and children carrying the s-allele showed 
higher levels of negative emotionality compared to l-allele carriers [42] and increased scores 
of anxiety and depression [43, 226]. Interestingly, platelets that bear SERT (generally accepted 
to be identical to neuronal SERT), VMAT2 and 5-HT
2
 receptors have been suspected to play a 
role in the emergence of autistic disease in human. Dysregulation in platelets function has been 
largely used as a marker of autism, however clarifications need to emerge from further studies 
(for review, see Refs. [227, 228].
Although the consequences are subtle, they reveal that both genetic and environmental SERT 
deficiency impact human development and increase the risks of future psychiatric diseases 
[229, 230]. Overall, these findings point to the general conclusion that various clinical patho-
logical traits, including autism, depression and anxiety-related phenotypes are associated to 
conditions of SERT deficiency during development. One should also consider that alteration 
of other genes may have synergistic effect on the emergence of those diseases or by contrast 
that bearing allelic variants of other genes could dampen the negative effects of SSRIs [231].
Rodent studies have revealed that the 5-HT
3A
 regulates cellular events involved in cortical circuit 
formation (see above). Human genetic studies have recently explored more deeply the involve-
ment of 5-HT
3A
 polymorphisms and methylation in the emergence of various pathological 
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traits and they now provide compelling evidence for such a role. In human genetic studies, 
it has been shown that a single-nucleotide polymorphism in 5-HT
3A
 (SNP; rs1062613) was 
associated with bipolar disease [232]. Moreover, allelic variants or specific levels of methyla-
tion of the 5-HT
3A
 have been shown to be tightly linked with alcohol-dependence, modulation 
of emotional networks and increase of depressive-related symptoms [233]. The emergence of 
depressive-like diseases was associated at the structural level with a decreased grey matter 
in the fronto-limbic region. Interestingly, 5-HT
3A
 has been shown to interact with the brain-
derived neurotrophic factor, a key factor for circuit formation and consolidation [234, 235]. 
Thus, genetic polymorphism or methylation of 5-HT
3A
 appears as a marker of susceptibility to 
develop a large panel of diseases.
Together, this further confirms complex connections between early-life stress and the sero-
toninergic systems.
6.2. Linking serotoninergic system and neonatal inflammation/ischaemia with the 
emergence of neuropsychiatric diseases in children and adults
Early-life inflammation modulates adulthood-inflammatory response [236]. In early brain 
injuries, activation of the immune system during fetal and neonatal life affects critical phases of 
brain development, with long-lasting consequences for neurological and mental health [237]. 
Neonatal stroke, systemic infection, or excitotoxicity/hypoxia-ischaemia (see Figure 5) induce 
perinatal insults activating the immune system and trigger peripheral and central responses 
that involve immune mediators (cytokines and chemokines), reactive oxygen species (ROS), 
reactive nitrosative species, excitotoxicity, mitochondrial impairment, and vascular integrity. 
In general, neonatal encephalopathy is of complex aetiology, encompassing several causal 
events, with strong evidence of fetal exposure to infection. The complex and multifactorial 
process of perinatal brain injury involves sensitization, whereby factors not severe enough by 
themselves to induce significant brain damage make the developing brain more susceptible 
to a second insult [238]. Substantial numbers of preclinical studies have demonstrated the 
sensitizing effects of gestational or neonatal systemic inflammation, gestational chronic mild 
maternal stress, and gestational hypoxia on perinatal excitotoxic or hypoxic-ischaemic lesions. 
Genetic factors have also been shown to influence the developing brain's response to sensitiz-
ing factors. Efforts to design therapies aimed to reduce the sensitizing effects of inflamma-
tion have been undertaken as neuroprotective agents, such as therapeutic hypothermia which 
have been performed mainly in models of pure hypoxia-ischaemia [238]. One of the main 
alterations following perinatal infection/inflammation is a persistent low-grade inflammation 
characterized by higher expression of inflammatory mediators and also microglial reactivity 
during adulthood [236]. Adult rodent exposed during early-life to LPS-enhanced expression 
of CD11b, IL-1β and IL-6 and also more activated microglia in the hippocampus, the striatum 
and substantia nigra/ventral tegmental area [239, 240]. This persistent low-grade inflamma-
tion sensitizes the brain to secondary injuries, which can lead to neurological disorders such 
as cerebral palsy, mood disorder, schizophrenia, or Parkinson disease [241].
Serotoninergic central system is vulnerable following a neonatal hypoxic-ischemic insult 
induced in a rat model [242] with a significant reduction in 5-HT levels, 5-HT transporter 
expression and 5-HT+ neurons is the dorsal raphe, 6 weeks after insult compared to control 
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animals. Inhibition of neuroinflammation by Minocycline within the first week after injury 
is sufficient to prevent long-term neuroinflammation as well as serotonergic system damage 
still. The loss of dorsal raphe 5-HT+ neurons has been suspected to be induced by an altera-
tion of one of their major target tissues: the prefrontal cortex [243].
7. Conclusion and perspectives
Both genetic and environmental factors that influence serotonin signalling during specific 
sensitive periods of development impact specific cellular events involved in the development 
of cortical circuits. Such alterations depending on the cellular target and the time of occur-
rence could result in a predisposition to a large spectrum of cognitive or psychiatric illnesses 
including autism and depression.
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